Evolution Research Group is Drug Discovery in United States that focus on clinical research business. Founded in 1998. They cover business area such as provider, clinical research and drug development service, simple and highly complex trial, psychiatric and neurological disorder, non-cns indication, early phase drug development service.
1998
( 26 years old in 2024 )
Clinical Research
-
430 Mountain Avenue
Suite 302
New Providence, NJ 07974
United States
Private
providerclinical research and drug development servicesimple and highly complex trialpsychiatric and neurological disordernon-cns indicationearly phase drug development service
* We use standard office opening hours in near Evolution Research Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Evolution Research Group is Drug Discovery business from United States that founded in 1998 (26 years old in 2024), Evolution Research Group business is focusing on Clinical Research.
Evolution Research Group headquarter office and corporate office address is located in 430 Mountain Avenue Suite 302 New Providence, NJ 07974 United States.
Evolution Research Group was founded in United States.
In 2024, Evolution Research Group is currently focus on clinical research sector.
Above is snippet of Google Trends for "clinical research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Evolution Research Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
